logo-loader
TSX-V:TBP

Tetra Bio-Pharma

Receive alerts
Market:
TSX-V
Market Cap:
$59.18 m
Price
0.21 CAD
Change
0.00%
52 weeks high
0.69
52 weeks low
0.17

In brief

Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries that are engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Biotech companies to dominate at Proactive One2One Virtual Investor Forum on June 23

TRACON Pharmaceuticals, Helix BioPharma, Tetra Bio-Pharma and MediPharm Labs are among the standouts presenting at the investor-focused event

1 week, 2 days ago